Ocular effects of imiquimod with treatment of eyelid melanoma in situ

Dermatologic Surgery

Volumn 33, Issue 9, 2007, Pages 1136-1138

  Murchison, Ann P ^a,b   Washington, Carl V ^a   Soloman, Alvin R ^a   Bernardino, C Robert ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; IMIQUIMOD; PETROLATUM;

AGED; ANAMNESIS; ARTICLE; CANCER SIZE; CASE REPORT; CHEMOSIS; COMPRESSION; CORNEA EDEMA; DISEASE DURATION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KERATOPATHY; MELANOMA; MICROSCOPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN SURGERY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CONJUNCTIVA; ERYTHEMA; EYELID NEOPLASMS; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; SKIN; SKIN NEOPLASMS; VISUAL ACUITY;

EID: 34548361865     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33232.x     Document Type: Article

References (4)

1. Li VW, Li WW, Talcott KE, Zhai AW. Imiquimod as an antiangiogenic agent. J Drugs Dermatol 2005 4 : 708 17.
2. Ray CM, Kluk M, Grin CM, Grant-Kels JM. Successful treatment of malignant melanoma in situ with topical imiquimod cream. Int J Dermatol 2005 44 : 428 34.
3. Urosevic M, Dummer R. Role of Imiquimod in skin cancer treatment. Am J Clin Dermatol 2004 5 : 453 8.
4. Wolf IH, Cerroni L, Kodama K, Kerl H. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod. Arch Dermatol 2005 141 : 510 4.